eCAM Advance Access originally published online on April 27, 2007
eCAM 2008 5(1):117-118; doi:10.1093/ecam/nem022
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2007 The Author(s).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Meeting Report |
Symposium on Pharmacovigilance of Herbal Medicines, London, March 28, 2006
1Center of Natural Medicine, S. Giuseppe Hospital, Az USL 11, Via Paladini 1, 50053 Empoli and 2Centre for Epidemiology, National Institute of Health, Rome, Italy
Keywords: adverse drug reaction – herbal medicine – pharmacovigilance
| The first 10% of the full text of this article appears below. |
On April 2006, the International Symposium Pharmacovigilance of Herbal Medicines. Current Status and Future Directions, was held in London, organized by the Royal Pharmaceutical Society of Great Britain (RPSGB) in conjunction with the most important international societies involved in the field. The Chairperson of the Congress was Prof. Joanna Barnes of the School of Pharmacy of the University of Auckland, NZ.
Major topics of the conference were: evaluation of main concerns about correct reports of adverse reactions to herbal extracts and possible future directions in organizing an international and affordable signaling system and to build a definitive international network on the WHO database.
Compelling problems are due to the wide differences that exist all over the world in nomenclature, administration, extraction and use of medicinal
For reprints and all correspondence: F. Firenzuoli Center of Natural Medicine S. Giuseppe Hospital, Az US[1], Via Paladini 1, 50053 Empoli, Italy. E-mail: f.firenzuoli@usl11.toscana.it